Innate Pharma SA (IPHA) will host a conference call on November 13, 2025, to discuss its Q3 2025 business progress. Key executives will present and answer questions. The call will be webcast live and available for replay on the company website. Innate Pharma focuses on developing immunotherapies, including lacutamab, IPH4502, and monalizumab. Investors will focus on clinical trial updates, cash runway, and competitive advantages. Note the presence of forward-looking statements subject to risks detailed in company filings.

OpenAI’s AI video generation app, Sora, has launched on Android in the U.S., Canada, Japan, South Korea, Taiwan, Thailand, and Vietnam, following its iOS debut. The Android expansion targets a larger global audience, aiming to drive adoption and refine AI algorithms. Sora allows users to create videos from text prompts, fostering a creative community similar to TikTok. Analysts predict a significant impact on creative fields due to Sora’s accessible and advanced generative AI video capabilities.

Sam Bankman-Fried, founder of the collapsed crypto exchange FTX, is appealing his fraud conviction, arguing his trial was “fundamentally unfair.” His attorney claims court rulings improperly limited his testimony, skewing the proceedings. Judges questioned the evidence of guilt and the impact of additional testimony. A key argument centers on whether FTX creditors have, or will be, fully compensated, potentially undermining the prosecution’s narrative of irreparable financial losses. The appeals court is scrutinizing the $11 billion forfeiture order and its implications for victim compensation. The decision will have significant consequences for Bankman-Fried and the wider crypto industry.

Kodiak Gas Services, Inc. (NYSE: KGS) will release its third-quarter 2025 financial results on November 5, 2025. A conference call and live webcast will be held at 11:00 a.m. Eastern Time to discuss the results and provide insights into the company’s performance and outlook. As a leading contract compression services provider, Kodiak plays a critical role in natural gas infrastructure, benefiting from robust demand and increasing midstream investments. The company reminds investors of potential risks and uncertainties in forward-looking statements, as detailed in their SEC filings.

IBM will reduce its global workforce by a low single-digit percentage in Q4, impacting around 2,700 positions. This realignment, driven by advancements in AI, mirrors similar moves by other tech giants like Amazon and Meta. Despite the cuts, IBM anticipates flat U.S. employment year-over-year. The company reported strong earnings and is actively diversifying into cloud computing, AI, and consulting under CEO Arvind Krishna, who has emphasized AI’s role in optimizing workflows. Previous staff reductions occurred in marketing and communications in March 2024.

Pinterest (PINS) shares plummeted nearly 20% after Q3 earnings missed EPS estimates and provided weak holiday season guidance. While revenue grew 17% year-over-year to $1.05 billion and MAUs reached 600 million, the forecast for Q4 revenue fell short of expectations. The company cited moderating ad spend in the U.S. and Canada due to tariff-related margin pressures for larger retailers, impacting the home furnishing category. Despite AI investments and user growth, Pinterest faces a competitive ad landscape dominated by tech giants.

Wave Life Sciences will present preclinical data for WVE-007 (INHBE GalNAc-siRNA) at ObesityWeek, showcasing its potential to drive fat loss while preserving muscle with infrequent dosing. Preclinical studies in DIO mice demonstrated significant weight loss, reduced visceral fat, and improved insulin sensitivity. When combined with semaglutide, weight loss doubled. Early clinical data from the INLIGHT trial show dose-dependent Activin E reductions (56-85%) that were sustained through six months. WVE-007 has shown a promising safety profile.

AMD’s Q3 results exceeded expectations with $9.25B revenue and $1.20 adjusted EPS. Revenue grew 36% YoY, driven by strong performance across key segments. Q4 revenue is projected at $9.6B, up 25% YoY, with a 54.5% gross margin. The company’s guidance excludes Instinct MI308 chip revenue to China. Strategic partnerships with OpenAI and Oracle, and Amazon’s sale of AMD shares highlight key developments. The company’s success in AI and other key areas intensifies its rivalry with Nvidia.

Super Micro Computer (SMCI) shares plunged 10% in after-hours trading as fiscal first-quarter results missed analyst expectations. EPS was 35 cents (adj.) versus 40 cents expected, and revenue reached $5.02 billion, below the $6 billion forecast. Revenue declined 15% year-over-year. Net income also more than halved. The company cited “design win upgrades” for the shortfall, shifting revenue to Q2, where they now forecast $10-$11 billion in sales. Despite benefiting from AI growth, SMCI’s growth seems to have slowed amid increasing competition.

Omdia reports record display glass revenues of JPY 270 billion in Q3 2025, up 14% year-over-year, driven by price increases and demand. Manufacturers prioritize profitability over market share, raising prices over 25% in two years and optimizing production. Chinese manufacturers are investing heavily in G8.5 glass, potentially impacting market share. Established players are diversifying into semiconductor and other high-margin applications to counter competition and secure future growth, suggesting a shift in the display glass market landscape.